Literature DB >> 15363973

Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons.

He-Bin Tang1, Atsuko Inoue, Kyoko Oshita, Yoshihiro Nakata.   

Abstract

Vanilloid receptor 1 was recently reported to play an important role in hyperalgesia, but the mechanisms by which this receptor is activated by endogenous inflammatory mediators, such as bradykinin and nerve growth factor, are not yet fully understood. Here, we investigated whether bradykinin, which is a pain-producing inflammatory mediator, sensitizes vanilloid receptor 1 by inducing the activation of cyclooxygenases, phospholipase C and phospholipase A2 in rat dorsal root ganglion cells. We demonstrated this using 45Ca2+ uptake and inositol phosphates accumulation assays, bradykinin activates phospholipase C and cyclooxygenase-1 through the bradykinin B2 receptor. The bradykinin B2 receptor then sensitizes vanilloid receptor 1 activity by facilitating non-selective Ca2+ channel activity, increasing the intracellular Ca2+ concentration from the extracellular pool. These methods would be useful for screening new drugs for activity at vanilloid receptor 1. These data suggest that endogenous substances produced by several enzymes may be capable of producing a synergistic response involving the vanilloid receptor 1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363973     DOI: 10.1016/j.ejphar.2004.07.076

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

1.  Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways.

Authors:  Xiao-Qing Pan; Jessica A Gonzalez; Shaohua Chang; Samuel Chacko; Alan J Wein; Anna P Malykhina
Journal:  Exp Neurol       Date:  2010-05-23       Impact factor: 5.330

Review 2.  Understanding inflammatory pain: ion channels contributing to acute and chronic nociception.

Authors:  John E Linley; Kirstin Rose; Lezanne Ooi; Nikita Gamper
Journal:  Pflugers Arch       Date:  2010-02-17       Impact factor: 3.657

Review 3.  Update: the search for the human cough receptor.

Authors:  Lorcan McGarvey
Journal:  Lung       Date:  2014-04-26       Impact factor: 2.584

4.  Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis.

Authors:  F Massa; A Sibaev; G Marsicano; H Blaudzun; M Storr; B Lutz
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

5.  TRPV1 in Pain and Itch.

Authors:  Fengxian Li; Fang Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  The activation of transient receptor potential vanilloid receptor subtype 1 by capsaicin without extracellular Ca2+ is involved in the mechanism of distinct substance P release in cultured rat dorsal root ganglion neurons.

Authors:  He-Bin Tang; Yoshihiro Nakata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-23       Impact factor: 3.000

Review 7.  Transient receptor potential vanilloid channels in hypertension, inflammation, and end organ damage: an imminent target of therapy for cardiovascular disease?

Authors:  Donna H Wang
Journal:  Curr Opin Cardiol       Date:  2008-07       Impact factor: 2.161

8.  TRESK gene recombinant adenovirus vector inhibits capsaicin-mediated substance P release from cultured rat dorsal root ganglion neurons.

Authors:  Jun Zhou; Shang-Long Yao; Cheng-Xiang Yang; Ji-Ying Zhong; Han-Bing Wang; Yan Zhang
Journal:  Mol Med Rep       Date:  2012-02-03       Impact factor: 2.952

9.  The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.

Authors:  Irina Vetter; Bruce D Wyse; Gregory R Monteith; Sarah J Roberts-Thomson; Peter J Cabot
Journal:  Mol Pain       Date:  2006-07-16       Impact factor: 3.395

10.  Inhibition of M current in sensory neurons by exogenous proteases: a signaling pathway mediating inflammatory nociception.

Authors:  John E Linley; Kirstin Rose; Mayur Patil; Brian Robertson; Armen N Akopian; Nikita Gamper
Journal:  J Neurosci       Date:  2008-10-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.